![Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/asset/787fb81a-bc5b-47fc-8dbc-5e3808361cd0/gr1.jpg)
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet
![Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring | Critical Care | Full Text Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-020-03000-7/MediaObjects/13054_2020_3000_Fig1_HTML.png)
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring | Critical Care | Full Text
![Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave](https://www.medwave.cl/medios/medwave/SuplEpis3/6320/fg01_6320EN.jpg)
Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease? - Medwave
![Pharmacological management of cerebral venous sinus thrombosis with full- dose IV heparin infusion and its clinical outcomes - ScienceDirect Pharmacological management of cerebral venous sinus thrombosis with full- dose IV heparin infusion and its clinical outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735675717302073-fx1.jpg)
Pharmacological management of cerebral venous sinus thrombosis with full- dose IV heparin infusion and its clinical outcomes - ScienceDirect
![PDF] Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. | Semantic Scholar PDF] Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/91b235faa3a1d8bd301c8387d81bade0a5cea3dd/2-Table1-1.png)